Human medicines European Public Assessment Report (EPAR): Exalief, eslicarbazepine acetate, Revision: 5, Withdrawn
06:50 EDT 7 Aug 2012 | European Medicines Agency
Original Article: Human medicines European Public Assessment Report (EPAR): Exalief, eslicarbazepine acetate, Revision: 5, Withdrawn
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Exalief, eslicarbazepine acetate, Revision: 5, Withdrawn"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
